Entropy Technologies LP Invests $1.60 Million in Cardinal Health, Inc. (NYSE:CAH)

Entropy Technologies LP acquired a new stake in Cardinal Health, Inc. (NYSE:CAH) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 13,495 shares of the company’s stock, valued at approximately $1,596,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Eastern Bank bought a new stake in shares of Cardinal Health during the 3rd quarter worth $25,000. Frazier Financial Advisors LLC grew its holdings in shares of Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after purchasing an additional 104 shares in the last quarter. Hara Capital LLC acquired a new stake in Cardinal Health during the third quarter worth $31,000. AM Squared Ltd bought a new stake in Cardinal Health in the third quarter valued at about $33,000. Finally, Carolina Wealth Advisors LLC bought a new stake in shares of Cardinal Health in the 3rd quarter valued at approximately $47,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Analysts Set New Price Targets

CAH has been the subject of a number of recent analyst reports. Morgan Stanley increased their target price on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research report on Friday, January 31st. Barclays boosted their target price on Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a report on Monday, November 4th. StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd. Finally, Bank of America raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and boosted their price target for the company from $132.00 to $145.00 in a report on Monday, January 6th. Four research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $136.87.

Cardinal Health Price Performance

Cardinal Health stock opened at $127.62 on Monday. The firm has a 50-day moving average of $122.46 and a 200-day moving average of $115.41. The company has a market cap of $30.83 billion, a price-to-earnings ratio of 23.81, a P/E/G ratio of 1.49 and a beta of 0.63. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $132.84.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.58%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is 37.69%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.